Of particular clinical relevance, the spatial distribution and quantitative expression of PD-1/PD-L1 within both tumor parenchyma and infiltrating immune cells have gained recognition as predictive biomarkers for patient outcomes in contemporary oncology. The gene discussed is CD274; the disease is neoplasm.